HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, vol.21, no.5, pp.337-345, 2006 (SCI-Expanded)
Article / Article
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Science Citation Index Expanded (SCI-EXPANDED), Scopus
venlafaxine, reboxetine, depression, anxiety, depression with anxiety features, treatment, DOUBLE-BLIND, FLUOXETINE, RELAPSE, NORADRENALINE, COMORBIDITY, ASSOCIATION, PREDICTORS, MANAGEMENT, DISORDERS, LIFETIME
Bursa Uludag University Affiliated:
Objective The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (MDD) and MDD with anxiety features to venlafaxine XR.